Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 3/20 | 0.35 |
| ▸ | PPARG | P37231 | 3/20 | 0.35 |
| ▸ | PTGES | O14684 | 2/20 | 0.35 |
| ▸ | PTGIR | P43119 | 1/20 | 0.35 |
| ▸ | SPHK2 | Q9NRA0 | 2/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.32 |
| ▸ | CETP | P11597 | 1/20 | 0.32 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16013506 | 0.85 | ALDH1A1 (0.40) | PPARG | |
| SCHEMBL16013507 | 0.85 | ALDH1A1 (0.40) | PPARG | |
| SCHEMBL16154815 | 0.85 | ALDH1A1 (0.40) | PPARG | |
| SCHEMBL19322735 | 0.72 | LPAR1 (0.41) | — | |
| SCHEMBL19322704 | 0.72 | LPAR1 (0.41) | — | |
| SCHEMBL16013342 | 0.72 | PLA2G2A (0.44) | — | |
| SCHEMBL16013343 | 0.72 | PLA2G2A (0.44) | — | |
| SCHEMBL9545663 | 0.71 | MEN1 (0.48) | PPARGSPHK2SPHK1CETPFAAH | |
| SCHEMBL21643923 | 0.71 | MEN1 (0.48) | PPARGSPHK2SPHK1CETPFAAH | |
| SCHEMBL9545661 | 0.71 | MEN1 (0.48) | PPARGSPHK2SPHK1CETPFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2964608-B1 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | NOVARTIS AG (CH) | 2019-08-28 | — | — | EP | disclosed |